Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE

Clinical trial NCT00461630 · COMPLETED

Trial details

NCT number: NCT00461630
Sponsor: University of Oxford
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiovascular Disease Peripheral Arterial Disease Diabetes Mellitus Coronary Heart Disease

Start date: 2007-01-01
Primary completion: 2012-10-01
Enrollment: 25673

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.